Geron
GERN
#5904
Rank
โ‚ฌ0.87 B
Marketcap
1,36ย โ‚ฌ
Share price
-2.84%
Change (1 day)
-14.46%
Change (1 year)

Earnings for Geron (GERN)

Earnings in 2025 (TTM): -โ‚ฌ41.76 Million

According to Geron's latest financial reports the company's current earnings are โ‚ฌ0.18 Billion. In 2024 the company made an earning of -โ‚ฌ0.14 Billion, an increase over its 2023 earnings that were of -โ‚ฌ0.16 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Geron from 1996 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -โ‚ฌ41.76 Million-69.11%
2024 -โ‚ฌ0.14 Billion-11.23%
2023 -โ‚ฌ0.16 Billion30.22%
2022 -โ‚ฌ0.12 Billion20.15%
2021 -โ‚ฌ97.32 Million50.08%
2020 -โ‚ฌ64.85 Million4.46%
2019 -โ‚ฌ62.08 Million130.68%
2018 -โ‚ฌ26.91 Million8.84%
2017 -โ‚ฌ24.73 Million-3.08%
2016 -โ‚ฌ25.51 Million-22080.6%
2015 โ‚ฌ0.11 M-100.38%
2014 -โ‚ฌ30.82 Million-7.14%
2013 -โ‚ฌ33.19 Million
2011 -โ‚ฌ78.52 Million19.04%
2010 -โ‚ฌ65.97 Million8.45%
2009 -โ‚ฌ60.83 Million-2.51%
2008 -โ‚ฌ62.4 Million14.65%
2007 -โ‚ฌ54.42 Million32.68%
2006 -โ‚ฌ41.02 Million25.59%
2005 -โ‚ฌ32.66 Million4.36%
2004 -โ‚ฌ31.3 Million19.73%
2003 -โ‚ฌ26.14 Million-15.46%
2002 -โ‚ฌ30.92 Million1.94%
2001 -โ‚ฌ30.33 Million33.59%
2000 -โ‚ฌ22.71 Million27.53%
1999 -โ‚ฌ17.8 Million63.13%
1998 -โ‚ฌ10.92 Million15.6%
1997 -โ‚ฌ9.44 Million-10.66%
1996 -โ‚ฌ10.57 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Gilead Sciences
GILD
โ‚ฌ8.56 B-21,626.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Incyte
INCY
โ‚ฌ1.37 B-3,558.39%๐Ÿ‡บ๐Ÿ‡ธ USA
CTI BioPharma
CTIC
-โ‚ฌ59.97 Million 50.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Bio-Techne
TECH
โ‚ฌ0.10 B-368.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
-โ‚ฌ8.22 Million-79.34%๐Ÿ‡บ๐Ÿ‡ธ USA